USD 0.83
(-2.0%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 3.02 Million USD | 267.38% |
2022 | 822.19 Thousand USD | -80.24% |
2021 | 4.16 Million USD | 301.06% |
2020 | 1.03 Million USD | -29.92% |
2019 | 1.48 Million USD | 199.41% |
2018 | 494.37 Thousand USD | 75.22% |
2017 | 282.14 Thousand USD | 454.3% |
2016 | 50.9 Thousand USD | 335.46% |
2015 | 11.68 Thousand USD | -29.53% |
2014 | 16.58 Thousand USD | -38.71% |
2013 | 27.06 Thousand USD | -52.0% |
2012 | 56.37 Thousand USD | -21.15% |
2011 | 71.5 Thousand USD | 5.7% |
2010 | 67.64 Thousand USD | 7.03% |
2009 | 63.2 Thousand USD | 66.35% |
2008 | 37.99 Thousand USD | 0.0% |
2007 | - USD | 0.0% |
2006 | - USD | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q1 | 1.57 Million USD | 14.08% |
2024 Q2 | 1.83 Million USD | 16.51% |
2023 Q4 | 1.38 Million USD | 41.73% |
2023 Q1 | 348.02 Thousand USD | 25.12% |
2023 Q2 | 315.9 Thousand USD | -9.23% |
2023 FY | 3.02 Million USD | 267.38% |
2023 Q3 | 974.89 Thousand USD | 208.61% |
2022 Q3 | 235.32 Thousand USD | 61.03% |
2022 FY | 822.19 Thousand USD | -80.24% |
2022 Q4 | 278.14 Thousand USD | 18.2% |
2022 Q1 | 162.59 Thousand USD | -94.67% |
2022 Q2 | 146.13 Thousand USD | -10.12% |
2021 Q2 | 208.47 Thousand USD | -69.54% |
2021 Q3 | 218.87 Thousand USD | 4.99% |
2021 FY | 4.16 Million USD | 301.06% |
2021 Q4 | 3.04 Million USD | 1292.69% |
2021 Q1 | 684.52 Thousand USD | 248.23% |
2020 FY | 1.03 Million USD | -29.92% |
2020 Q3 | 336.07 Thousand USD | 36.57% |
2020 Q4 | 196.57 Thousand USD | -41.51% |
2020 Q2 | 246.07 Thousand USD | -4.83% |
2020 Q1 | 258.57 Thousand USD | -21.3% |
2019 FY | 1.48 Million USD | 199.41% |
2019 Q2 | 658.63 Thousand USD | 247.69% |
2019 Q1 | 189.43 Thousand USD | 22.22% |
2019 Q3 | 303.57 Thousand USD | -53.91% |
2019 Q4 | 328.57 Thousand USD | 8.24% |
2018 Q3 | 125.03 Thousand USD | 13.45% |
2018 FY | 494.37 Thousand USD | 75.22% |
2018 Q1 | 104.14 Thousand USD | 28.01% |
2018 Q4 | 154.99 Thousand USD | 23.96% |
2018 Q2 | 110.21 Thousand USD | 5.83% |
2017 Q4 | 81.35 Thousand USD | 19.25% |
2017 FY | 282.14 Thousand USD | 454.3% |
2017 Q3 | 68.22 Thousand USD | -15.08% |
2017 Q2 | 80.33 Thousand USD | 53.77% |
2017 Q1 | 52.24 Thousand USD | 448.91% |
2016 FY | 50.9 Thousand USD | 335.46% |
2016 Q4 | 9517.00 USD | -46.63% |
2016 Q3 | 17.83 Thousand USD | 227.41% |
2016 Q2 | 5446.00 USD | -69.92% |
2016 Q1 | 18.1 Thousand USD | 0.0% |
2015 Q4 | - USD | -100.0% |
2015 Q3 | 2513.00 USD | -54.73% |
2015 Q1 | 3625.00 USD | 0.0% |
2015 Q2 | 5551.00 USD | 53.13% |
2015 FY | 11.68 Thousand USD | -29.53% |
2014 FY | 16.58 Thousand USD | -38.71% |
2013 FY | 27.06 Thousand USD | -52.0% |
2012 FY | 56.37 Thousand USD | -21.15% |
2011 Q1 | 33.05 Thousand USD | 11.47% |
2011 Q2 | 21.79 Thousand USD | -34.08% |
2011 Q3 | 12.87 Thousand USD | -40.9% |
2011 Q4 | 3775.00 USD | -70.69% |
2011 FY | 71.5 Thousand USD | 5.7% |
2010 FY | 67.64 Thousand USD | 7.03% |
2010 Q1 | 26.82 Thousand USD | 288.36% |
2010 Q4 | 29.65 Thousand USD | 0.0% |
2010 Q2 | 11.17 Thousand USD | -58.34% |
2010 Q3 | - USD | -100.0% |
2009 Q3 | 2852.00 USD | -82.85% |
2009 Q1 | 36.81 Thousand USD | -92.32% |
2009 FY | 63.2 Thousand USD | 66.35% |
2009 Q4 | 6906.00 USD | 142.15% |
2009 Q2 | 16.63 Thousand USD | -54.83% |
2008 Q3 | - USD | 0.0% |
2008 Q2 | - USD | 0.0% |
2008 Q1 | - USD | 0.0% |
2008 Q4 | 479.34 Thousand USD | 0.0% |
2008 FY | 37.99 Thousand USD | 0.0% |
2007 FY | - USD | 0.0% |
2007 Q4 | - USD | 0.0% |
2007 Q2 | - USD | 0.0% |
2007 Q1 | - USD | 0.0% |
2007 Q3 | - USD | 0.0% |
2006 FY | - USD | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
Accelerate Diagnostics, Inc. | 12.05 Million USD | 74.952% |
BrainsWay Ltd. | 31.78 Million USD | 90.497% |
Cerus Corporation | 156.36 Million USD | 98.068% |
Envoy Medical, Inc. | 316 Thousand USD | -855.878% |
electroCore, Inc. | 16.03 Million USD | 81.157% |
Helius Medical Technologies, Inc. | 644 Thousand USD | -369.033% |
IceCure Medical Ltd | 3.22 Million USD | 6.455% |
Inogen, Inc. | 315.66 Million USD | 99.043% |
OrthoPediatrics Corp. | 148.73 Million USD | 97.969% |
Lucid Diagnostics Inc. | 2.42 Million USD | -24.406% |
Monogram Orthopaedics, Inc. | 364.99 Thousand USD | -727.557% |
MaxCyte, Inc. | 41.28 Million USD | 92.684% |
NeuroOne Medical Technologies Corporation | 1.95 Million USD | -54.708% |
Nexalin Technology, Inc. | 110.74 Thousand USD | -2627.431% |
Orthofix Medical Inc. | 746.64 Million USD | 99.595% |
PAVmed Inc | 2.45 Million USD | -23.188% |
Rapid Micro Biosystems, Inc. | 22.51 Million USD | 86.587% |
RxSight, Inc. | 89.07 Million USD | 96.609% |
Sight Sciences, Inc. | 81.05 Million USD | 96.273% |
SI-BONE, Inc. | 138.88 Million USD | 97.825% |
TELA Bio, Inc. | 58.45 Million USD | 94.832% |
Treace Medical Concepts, Inc. | 187.11 Million USD | 98.386% |
Vivos Therapeutics, Inc. | 13.8 Million USD | 78.113% |
Acutus Medical, Inc. | 7.16 Million USD | 57.837% |
Talis Biomedical Corporation | 412 Thousand USD | -633.149% |
Spectral AI, Inc. | 18.05 Million USD | 83.271% |
Nano-X Imaging Ltd. | 9.9 Million USD | 69.505% |
CVRx, Inc. | 39.29 Million USD | 92.313% |
DIH Holding US, Inc. Warrants | - USD | -Infinity% |
PetVivo Holdings, Inc. | 968.7 Thousand USD | -211.815% |
Bioventus Inc. | 512.34 Million USD | 99.41% |
Venus Concept Inc. | 76.35 Million USD | 96.044% |
TriSalus Life Sciences, Inc. | 18.51 Million USD | 83.682% |
LivaNova PLC | 1.15 Billion USD | 99.738% |
908 Devices Inc. | 50.22 Million USD | 93.986% |
Alphatec Holdings, Inc. | 482.26 Million USD | 99.374% |
Nemaura Medical Inc. | 77.04 Thousand USD | -3820.584% |
NeuroPace, Inc. | 65.42 Million USD | 95.383% |
LENSAR, Inc. | 42.16 Million USD | 92.836% |
Apyx Medical Corporation | 52.34 Million USD | 94.23% |
Cutera, Inc. | 212.36 Million USD | 98.578% |
STRATA Skin Sciences, Inc. | 33.35 Million USD | 90.945% |
BioSig Technologies, Inc. | 18 Thousand USD | -16680.972% |
Anika Therapeutics, Inc. | 166.66 Million USD | 98.188% |
ClearPoint Neuro, Inc. | 23.95 Million USD | 87.391% |
Integra LifeSciences Holdings Corporation | 1.54 Billion USD | 99.804% |
Axonics, Inc. | 366.37 Million USD | 99.176% |
Outset Medical, Inc. | 130.37 Million USD | 97.683% |
IRIDEX Corporation | 51.86 Million USD | 94.177% |
PROCEPT BioRobotics Corporation | 136.19 Million USD | 97.782% |
IRadimed Corporation | 65.56 Million USD | 95.393% |
Tivic Health Systems, Inc. | 1.17 Million USD | -156.852% |
Telesis Bio, Inc. | 27.5 Million USD | 89.02% |
Viemed Healthcare, Inc. | 183 Million USD | 98.349% |
Varex Imaging Corporation | 811 Million USD | 99.628% |
Quipt Home Medical Corp. | 221.74 Million USD | 98.638% |
Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
Pulmonx Corporation | 68.67 Million USD | 95.602% |
Dynatronics Corporation | 32.53 Million USD | 90.716% |
Modular Medical, Inc. | - USD | -Infinity% |
ReShape Lifesciences Inc. | 8.67 Million USD | 65.193% |
Semler Scientific, Inc. | 68.18 Million USD | 95.57% |
InMode Ltd. | 492.04 Million USD | 99.386% |
Bruker Corporation | 2.96 Billion USD | 99.898% |
Cytosorbents Corporation | 36.34 Million USD | 91.69% |
DexCom, Inc. | 3.62 Billion USD | 99.917% |
Align Technology, Inc. | 3.86 Billion USD | 99.922% |
Viveve Medical, Inc. | 6.42 Million USD | 52.994% |
ZimVie Inc. | 457.43 Million USD | 99.34% |
Movano Inc. | - USD | -Infinity% |
Cytek Biosciences, Inc. | 193.01 Million USD | 98.435% |
Nexalin Technology, Inc. | 110.74 Thousand USD | -2627.431% |
DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
Tandem Diabetes Care, Inc. | 747.71 Million USD | 99.596% |
Profound Medical Corp. | 7.33 Million USD | 58.797% |
Insulet Corporation | 1.69 Billion USD | 99.822% |
enVVeno Medical Corporation | - USD | -Infinity% |
Surmodics, Inc. | 126.07 Million USD | 97.604% |
iCAD, Inc. | 17.31 Million USD | 82.558% |
Nuwellis, Inc. | 8.86 Million USD | 65.923% |
Biotricity, Inc. | 12.06 Million USD | 74.961% |
iRhythm Technologies, Inc. | 492.68 Million USD | 99.387% |
Aethlon Medical, Inc. | - USD | -Infinity% |
InspireMD, Inc. | 6.2 Million USD | 51.32% |
PAVmed Inc. | 2.45 Million USD | -23.188% |
BIOLASE, Inc. | 49.16 Million USD | 93.856% |
Beyond Air, Inc. | 1.15 Million USD | -160.619% |
FONAR Corporation | 102.88 Million USD | 97.064% |
AxoGen, Inc. | 159.01 Million USD | 98.1% |
Vivani Medical, Inc. | - USD | -Infinity% |
Tactile Systems Technology, Inc. | 274.42 Million USD | 98.899% |
Inari Medical, Inc. | 493.63 Million USD | 99.388% |
UFP Technologies, Inc. | 400.07 Million USD | 99.245% |
QT Imaging Holdings, Inc. | - USD | -Infinity% |
Heart Test Laboratories, Inc. | 18.6 Thousand USD | -16139.651% |
Tenon Medical, Inc. | 2.92 Million USD | -3.162% |
Autonomix Medical, Inc. Common Stock | - USD | -Infinity% |
Co-Diagnostics, Inc. | 6.81 Million USD | 55.658% |
AdaptHealth Corp. | 3.2 Billion USD | 99.906% |
Sintx Technologies, Inc. | 2.62 Million USD | -14.982% |
NanoVibronix, Inc. | 2.28 Million USD | -32.307% |
Quanterix Corporation | 122.36 Million USD | 97.532% |
Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
Sensus Healthcare, Inc. | 24.4 Million USD | 87.623% |
Pacific Biosciences of California, Inc. | 200.52 Million USD | 98.494% |
TransMedics Group, Inc. | 241.62 Million USD | 98.75% |
ReWalk Robotics Ltd. | 13.85 Million USD | 78.197% |
NeuroMetrix, Inc. | 5.9 Million USD | 48.816% |
Hyperfine, Inc. | 11.03 Million USD | 72.62% |
Establishment Labs Holdings Inc. | 165.15 Million USD | 98.171% |
Biomerica, Inc. | 5.41 Million USD | 44.218% |
Bone Biologics Corporation | - USD | -Infinity% |
AVITA Medical, Inc. | 50.56 Million USD | 94.026% |
Bluejay Diagnostics, Inc. | - USD | -Infinity% |
Silk Road Medical, Inc | 177.13 Million USD | 98.295% |